Literature DB >> 2548593

Characterization of free radicals produced during oxidation of etoposide (VP-16) and its catechol and quinone derivatives. An ESR Study.

B Kalyanaraman1, J Nemec, B K Sinha.   

Abstract

Spectroscopic evidence for the radical-mediated metabolism of VP-16, VP-16 catechol, and VP-16 quinone during enzymatic oxidation and autoxidation has been obtained. Autoxidation of the catechol yields the primary semiquinone together with the primary molecular product VP-16 quinone, which subsequently undergoes hydrolytic oxidation to form secondary quinones and semiquinones. Both primary and secondary phenoxyl radicals were detected during peroxidatic oxidation of VP-16. Neither the primary nor the secondary radicals react with DNA at a detectable rate. Evidence for the production of hydroxyl radical during iron-catalyzed oxidation of VP-16 catechol was obtained. These free radical reactions may have implications for the mechanism of antitumor action of VP-16.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548593     DOI: 10.1021/bi00437a048

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  12 in total

1.  Myeloperoxidase-dependent oxidation of etoposide in human myeloid progenitor CD34+ cells.

Authors:  Irina I Vlasova; Wei-Hong Feng; Julie P Goff; Angela Giorgianni; Duc Do; Susanne M Gollin; Dale W Lewis; Valerian E Kagan; Jack C Yalowich
Journal:  Mol Pharmacol       Date:  2010-11-19       Impact factor: 4.436

2.  Effect of nitric oxide on the anticancer activity of the topoisomerase-active drugs etoposide and adriamycin in human melanoma cells.

Authors:  Birandra K Sinha; Ashutosh Kumar; Suchandra Bhattacharjee; Michael G Espey; Ronald P Mason
Journal:  J Pharmacol Exp Ther       Date:  2013-09-18       Impact factor: 4.030

Review 3.  Topoisomerase inhibitors. A review of their therapeutic potential in cancer.

Authors:  B K Sinha
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

4.  Antitumor agents. 126. Novel 4 beta-substituted anilino derivatives of 3',4'-O,O-didemethylpodophyllotoxin as potent inhibitors of human DNA topoisomerase II.

Authors:  Z Q Wang; Y C Shen; H X Chen; J Y Chang; X Guo; Y C Cheng; K H Lee
Journal:  Pharm Res       Date:  1993-03       Impact factor: 4.200

5.  Thiols oxidation and covalent binding of BSA by cyclolignanic quinones are enhanced by the magnesium cation.

Authors:  Antonio E Alegria; Pedro Sanchez-Cruz; Ajay Kumar; Carmelo Garcia; Fernando A Gonzalez; Aimee Orellano; Beatriz Zayas; Marina Gordaliza
Journal:  Free Radic Res       Date:  2008-01

6.  IS METABOLIC ACTIVATION OF TOPOISOMERASE II POISONS IMPORTANT IN THE MECHANISM OF CYTOTOXICITY?

Authors:  Birandra K Sinha; Ronald P Mason
Journal:  J Drug Metab Toxicol       Date:  2015-07-24

7.  Role of the semi-quinone free radical of the anti-tumour agent etoposide (VP-16-213) in the inactivation of single- and double-stranded phi X174 DNA.

Authors:  D R Mans; J Retèl; J M van Maanen; M V Lafleur; M A van Schaik; H M Pinedo; J Lankelma
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

8.  Delta-ALA-D activity is a reliable marker for oxidative stress in bone marrow transplant patients.

Authors:  Thissiane L Gonçalves; Dalila M Benvegnú; Gabriela Bonfanti; Andressa V Frediani; João Batista T Rocha
Journal:  BMC Cancer       Date:  2009-05-08       Impact factor: 4.430

9.  DNA-AP sites generation by etoposide in whole blood cells.

Authors:  Emilio Rojas; Patricia Mussali; Efrain Tovar; Mahara Valverde
Journal:  BMC Cancer       Date:  2009-11-16       Impact factor: 4.430

10.  Role of nitric oxide in the chemistry and anticancer activity of etoposide (VP-16,213).

Authors:  Birandra K Sinha; Suchandra Bhattacharjee; Saurabh Chatterjee; JinJie Jiang; Ann G Motten; Ashutosh Kumar; Michael Graham Espey; Ronald P Mason
Journal:  Chem Res Toxicol       Date:  2013-02-26       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.